UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Multiple sclerosis, 2010-03, Vol.16 (3), p.342-350

2010

Volltextzugriff (PDF)

Variable results after rituximab in neuromyelitis optica

Journal of the neurological sciences, 2012-06, Vol.317 (1), p.103-105

2012

Volltextzugriff (PDF)

Sudden unexpected death on fingolimod

Multiple sclerosis, 2012-10, Vol.18 (10), p.1507-1508

2012

Volltextzugriff (PDF)

Dexamethasone-induced Ras-related protein 1 is a potential regulatory protein in B lymphocytes

International immunology, 2007-05, Vol.19 (5), p.583-590

Lindsey, JW

2007

Volltextzugriff (PDF)

Antivirus immune activity in multiple sclerosis correlates with MRI activity

Acta neurologica Scandinavica, 2016-01, Vol.133 (1), p.17-24

2016

Volltextzugriff (PDF)

Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis

European journal of neurology, 2010-10, Vol.17 (10), p.1263-1269

2010

Volltextzugriff (PDF)

The antibody response to Epstein–Barr virions is altered in multiple sclerosis

Journal of neuroimmunology, 2013-01, Vol.254 (1), p.146-153

2013

Volltextzugriff (PDF)

Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis

Annals of neurology, 1994-08, Vol.36 (2), p.183-189

1994

Volltextzugriff (PDF)

Epstein-Barr virus genotypes in multiple sclerosis

Acta neurologica Scandinavica, 2008-02, Vol.117 (2), p.141-144

2008

Volltextzugriff (PDF)

Phase 1 clinical trial of chimeric monoclonal anti-CD4 antibody in multiple sclerosis

Neurology, 1994-03, Vol.44 (3 Pt 1), p.413-413

1994

Volltextzugriff (PDF)

Immune regulatory effects of central nervous system antigens in culture

International immunology, 2000-11, Vol.12 (11), p.1605-1612

2000

Volltextzugriff (PDF)

Diverse T cell receptor V beta gene usage in the central nervous system in experimental allergic encephalomyelitis

The Journal of immunology (1950), 1993-05, Vol.150 (9), p.4085-4092

1993

Volltextzugriff (PDF)

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

Multiple sclerosis, 2015-09, Vol.21 (10), p.1322-1331

2015

Volltextzugriff (PDF)

Usage of T cell receptor beta-chain variable gene is highly restricted at the site of inflammation in murine autoimmune uveitis

The Journal of immunology (1950), 1993-06, Vol.150 (12), p.5716-5721

1993

Volltextzugriff (PDF)

Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis

Archives of neurology (Chicago), 1997-06, Vol.54 (6), p.731-736

1997

Volltextzugriff (PDF)

An alkali-soluble factor present in normal brain tissue inhibits antigen-specific lymphocyte proliferation

Journal of neuroimmunology, 2000-02, Vol.103 (1), p.76-83

Lindsey, J.William

2000

Volltextzugriff (PDF)

Controlled trial of isoniazid therapy for severe postural cerebellar tremor in multiple sclerosis

Neurology, 1985-09, Vol.35 (9), p.1374-1374

1985

Volltextzugriff (PDF)

Use of reinduced experimental autoimmune encephalomyelitis to evaluate the importance of epitope spread

International immunology, 1998-06, Vol.10 (6), p.743-748

Lindsey, J W

1998

Volltextzugriff (PDF)

Reinduction of Experimental Autoimmune Encephalomyelitis in Mice

Cellular immunology, 1995-05, Vol.162 (2), p.235-240

1995

Volltextzugriff (PDF)

Competitive PCR quantification of CD4, CD8, ICAM-1, VCAM-1, and MHC class II mRNA in the central nervous system during development and resolution of experimental allergic encephalomyelitis

Journal of neuroimmunology, 1993-11, Vol.48 (2), p.227-234

1993

Volltextzugriff (PDF)

Characteristics of initial and reinduced experimental autoimmune encephalomyelitis

Immunogenetics (New York), 1996, Vol.44 (4), p.292-297, Article 292

Lindsey, J W

1996

Volltextzugriff (PDF)

47-year-old woman with six-week history of lower extremity weakness and eosinophilia

The Western journal of medicine, 1992-05, Vol.156 (5), p.517

1992

Volltextzugriff (PDF)

Prevalence and sociodemographic correlates of antinuclear antibodies in the United States

Arthritis & rheumatology (Hoboken, N.J.), 2012-07, Vol.64 (7), p.2319-2327

2012

Volltextzugriff (PDF)

Universal features of post-transcriptional gene regulation are critical for Plasmodium zygote development

PLoS pathogens, 2010-02, Vol.6 (2), p.e1000767-e1000767

2010

Volltextzugriff (PDF)

1 – 25 von 499

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(469)
Mit Volltextzugriff
(397)

Publikationsform

Artikel
(498)
magazinearticle
(1)

Sprache

Englisch
(499)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Variable results after rituximab in neuromyelitis optica

Sudden unexpected death on fingolimod

Dexamethasone-induced Ras-related protein 1 is a potential regulatory protein in B lymphocytes

Antivirus immune activity in multiple sclerosis correlates with MRI activity

Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis

The antibody response to Epstein–Barr virions is altered in multiple sclerosis

Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis

Epstein-Barr virus genotypes in multiple sclerosis

Phase 1 clinical trial of chimeric monoclonal anti-CD4 antibody in multiple sclerosis

Immune regulatory effects of central nervous system antigens in culture

Diverse T cell receptor V beta gene usage in the central nervous system in experimental allergic encephalomyelitis

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

Usage of T cell receptor beta-chain variable gene is highly restricted at the site of inflammation in murine autoimmune uveitis

Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis

An alkali-soluble factor present in normal brain tissue inhibits antigen-specific lymphocyte proliferation

Controlled trial of isoniazid therapy for severe postural cerebellar tremor in multiple sclerosis

Use of reinduced experimental autoimmune encephalomyelitis to evaluate the importance of epitope spread

Reinduction of Experimental Autoimmune Encephalomyelitis in Mice

Competitive PCR quantification of CD4, CD8, ICAM-1, VCAM-1, and MHC class II mRNA in the central nervous system during development and resolution of experimental allergic encephalomyelitis

Characteristics of initial and reinduced experimental autoimmune encephalomyelitis

47-year-old woman with six-week history of lower extremity weakness and eosinophilia

Prevalence and sociodemographic correlates of antinuclear antibodies in the United States

Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease

Universal features of post-transcriptional gene regulation are critical for Plasmodium zygote development

Aktive Filter

Suchergebnisse filtern